IHE Publications
-
Publications
- All Publications
- Books
- Consensus Statements
- Economic Reports
- Environmental Scan
- Evidence Review
-
Health Technology Assessments /
Systematic Reviews - Health Topic Overviews / Scoping Reviews
- HTA Policy
- IHE Discussion Paper
- IHE Roundtable Report
- Journal Articles
- Methodology Papers
- Overview of Systematic Reviews
- Policy Report
- Rapid Reviews
- Statistics Handbooks
- Summary Reports
- News/Events
- General Content
- Adaptation
- Benefits Design
- Cancer
- Chronic Diseases / Disorders
- Community Health Centres
- Constraints
- COPD
- Core Data Set
- Cost-effectiveness analysis
- COVID-19
- Deliberative Processes
- Diabetes
- Diagnosis
- Diagnostic screening
- Diagonal approach
- Digital Health
- Economic Evaluation
- Extreme Heat Events
- Fetal Alcohol Spectrum Disorder (FASD)
- Funding Models
- Genetic Testing
- Health Data
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Health Topic Overviews
- Healthcare Services
- Heart Disease
- Heart Failure
- Immunology
- Infectious Diseases
- Innovation
- Life-Cycle
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Opioid substance use disorder
- Other
- Pharmaceutical Policy
- Pharmaceuticals
- Policy Roundtable
- Precision Medicine
- Precision Oncology
- Prevention
- Primary Care
- Priority-Setting
- Psoriasis
- Quality of Life
- Regulatory Approval
- Reimbursement
- Scoping Reviews
- Screening
- Spillover effects
- Surveillance
- Telehealth
- Therapy
- Uncertainty
- Vaccines
- Akpinar, Ilke
- Bond, Ken
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Guo, Bing
- Harback, Kate
- Institute of Health Economics, IHE
- Kirwin, Erin
- Lopatina, Elena
- McCabe, Christopher
- Moga, Carmen
- Palfrey, Dan
- Pollock, Michelle
- Rafferty, Ellen
- Razavilar, Negar
- Round, Jeff
- Seida, Jennifer
- Sproule, John
- Sutton, Andrew J.
- Tjosvold, Lisa
- Tran, Dat
- Warkentin, Lindsey
- Wright, Erica
- Yan, Charles
Theoretical models of the cost-effectiveness threshold, value assessment, and health care system sustainability
As the Federal Government contemplates introducing an element of value-based pricing to the pharmaceutical industry regulatory framework, this report provides an overview of key theoretical and empirical material, to support informed engagement by all stakeholders in this important debate.
Publication Type: Economic Reports
Year of Publication: 2018
Topics: Health Economics / Healthcare Costs, Pharmaceuticals
Authors: Himani Pandey, Mike Paulden, Christopher McCabe
ISBN (online): 978-1-926929-89-7